No Data
Verona Pharma Price Target Raised to $107.00/Share From $93.00 by Wells Fargo
Analysts' Opinions Are Mixed on These Healthcare Stocks: The Ensign Group (ENSG), Verona Pharma (VRNA) and Atricure (ATRC)
Verona Pharma Is Maintained at Buy by HC Wainwright & Co.
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Incyte (INCY) and Verona Pharma (VRNA)
Verona Pharma Analyst Ratings
Analysts Are Betting On Verona Pharma Plc (NASDAQ:VRNA) With A Big Upgrade This Week